Marksans Pharma Limited — Board Meeting, 26-05-2026: Outcome of Board Meeting

Marksans Pharma's Board approved consolidated financial results for the quarter and financial year ending March 31, 2026. A final dividend of Rs 0.90 per share for FY26 was also approved, subject to shareholder approval.